New
HealthMore in Health→
MAHA Goes Corporate: Health Industry Takes Center Stage as Medicare Pricing Push Falters
Key Takeaways
- STAT News framed its coverage around the headline "MAHA goes corporate," noting that health care companies dominated the MAHA Summit.
- The same reporting covers a Trump administration effort to lower Medicare drug prices that has been substantially watered down.
- Adam Feuerstein's Biotech Scorecard, dated October 1, 2026, examines why a Huntington's patient is not fazed by the waning effect of UniQure's gene therapy.
- Together the threads highlight the tension between a movement built on criticizing the health industry and its growing corporate alignment.
DE
DT Editorial Team··via statnews.com